✦ LIBER ✦

Quality of life as an outcome in clinical trials and cancer care: A primer for surgeons

✍ Scribed by Giles F. Whalen; Carol Estwing Ferrans

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 92 KB
Volume: 77
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.1107

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality of life as an endpoint in EORTC

Quality of life as an endpoint in EORTC clinical trials

✍ Gwendoline M. Kiebert; Desmond Curran; Neil K. Aaronson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

For more than 30 years the European Organization for Research and Treatment for Cancer (EORTC) has conducted, co-ordinated, and stimulated research on the experimental and clinical bases of treatment of cancer and related problems. For more than a decade the EORTC has included quality of life as an

Health-related quality of life measures

✍ David A. Stevenson; John C. Carey 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Quality of life as an outcome variable i

Quality of life as an outcome variable in the management of cancer pain

✍ Betty R. Ferrell; Cheryl Wisdom; Carol Wenzl 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 614 KB

SUMMARY MEASURES AND STATISTICS FOR COMP

SUMMARY MEASURES AND STATISTICS FOR COMPARISON OF QUALITY OF LIFE IN A CLINICAL TRIAL OF CANCER THERAPY

✍ DIANE L. FAIRCLOUGH 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 3 views

Assessment of health related quality of life (QOL) has become an important endpoint in many clinical trials of cancer therapy. Most of these studies entail multiple QOL scales that are assessed repeatedly over time. As a result, the problem of multiple comparisons is a primary analytic challenge wit

Statistical analysis of quality of life

Statistical analysis of quality of life with missing data in cancer clinical trials

✍ Andrea B. Troxel; Diane L. Fairclough; Desmond Curran; Elizabeth A. Hahn 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 3 views

We summarize issues that arise when considering quality of life (QOL) data in cancer clinical trials, especially those related to missing data. We describe different types of missing data mechanisms, and discuss ways of assessing and testing missing data mechanisms. A section on presentation of stud

Missing quality of life data in cancer c

Missing quality of life data in cancer clinical trials: serious problems and challenges

✍ Jürg Bernhard; David F. Cella; Alan S. Coates; Lesley Fallowfield; Patricia A. G 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 2 views

Measurement of quality of life (QOL) in cancer clinical trials has increased in recent years as more groups realize the importance of such endpoints. A key problem has been missing data. Some QOL data may unavoidably be missing, as for example when patients are too ill to complete forms. Other impor